$LLY News Article - FDA Approves Lilly's Zepbound(TM) (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems
https://marketwirenews.com/news-releases/fda-...54149.html